METIS innovative
VC Fund
Miami Beach, United States
METIS innovative is a VC fund in Miami Beach focused on Medical and Medical Device. Metis Innovative was formed in 2017 as an investment vehicle for promising early stage medical devices and technology in the neurosciences. Founded by two prominent neurosurgeons in academic practice and a veteran of capital accrual for investment opportunities, the firm’s mission is to identify and invest in unique, well positioned companiesfocused on scientific breakthroughs.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries METIS innovative invests in
Stages METIS innovative invests in
Countries METIS innovative invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $19M–$27M
Investment Focus
Industry
- Medical 3 (43%)
- Medical Device 2 (29%)
- Robotics 1 (14%)
- Health Care 1 (14%)
- Neuroscience 1 (14%)
Stage
- Series A 2 (29%)
- Seed 1 (14%)
- Series B 1 (14%)
- Series C 1 (14%)
- Series D 1 (14%)
Country
- United States 2 (29%)
- Canada 1 (14%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Brian Sidman
Co-Founder, Principal; Co-Founder, Principal
|
Co-Founder, Principal; Co-Founder, Principal | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Phantom Neuro develops innovative muscle-machine interfaces that enhance robotic limb rehabilitation. The company focuses on creating solutions that improve mobility for users by integrating neurotechnology with robotic systems. Through its minimally invasive approach, Phantom Neuro aims to facilitate precise control of robotic limbs, allowing formore natural movement and better user experiences. The company is committed to advancing the field of neurotechnology, providing valuable tools for rehabilitation and improving the quality of life for individuals with mobility challenges. Phantom Neuro also explores various applications of its technologies, contributing to the broader field of assistive robotics. | $19M / Series A / Apr 15, 2025 | ||
| Fluid Biotech is a Calgary based company that aims to develop the next generation of stents to improve patient well-being and realise better health and quality of life through innovation. | $27M / Series A / Dec 16, 2024 | ||
| Synchron manufactures and markets a medical device that can be delivered to the brain with a catheter to record neuron signals that might be used to control an advanced prosthetic. | $75M / Series C / Dec 16, 2022 | ||
| Synchron manufactures and markets a medical device that can be delivered to the brain with a catheter to record neuron signals that might be used to control an advanced prosthetic. | $75M / Series C / Dec 15, 2022 | ||
| Fluid Biotech is a Calgary based company that aims to develop the next generation of stents to improve patient well-being and realise better health and quality of life through innovation. | $4.7M / Seed / Aug 11, 2021 | ||
| Synchron manufactures and markets a medical device that can be delivered to the brain with a catheter to record neuron signals that might be used to control an advanced prosthetic. | $40M / Series B / Jun 03, 2021 | ||
| Synchron manufactures and markets a medical device that can be delivered to the brain with a catheter to record neuron signals that might be used to control an advanced prosthetic. | $200M / Series D |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does METIS innovative invest in?
METIS innovative invests primarily in Medical, Medical Device and Robotics startups, most often at Series A and Seed stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is METIS innovative's check size?
METIS innovative typically joins rounds of $19M–$27M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds METIS innovative participates in.
How do I contact METIS innovative?
Public channels for METIS innovative include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at METIS innovative?
The team at METIS innovative includes Brian Sidman (Co-Founder, Principal; Co-Founder, Principal). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
